Metallothionein II treatment mitigates rotenone-induced neurodegeneration in zebrafish models of Parkinson’s disease
IntroductionParkinson’s disease (PD) is a common neurodegenerative disorder primarily affecting motor function due to progressive loss of dopaminergic neurons in the substantia nigra. Current therapies offer symptomatic relief but fail to halt disease progression, highlighting the need for novel the...
Saved in:
Main Authors: | Yong Hui Nies, Wei Ling Lim, Norwahidah Abd Karim, Mohamad Fairuz Yahaya, Seong Lin Teoh |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1478013/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity
by: Daniel Torrente, et al.
Published: (2025-01-01) -
Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
by: Virendra Kumar Yadav, et al.
Published: (2025-01-01) -
Neuroprotective Effect of Melatonin Loaded in Human Serum Albumin Nanoparticles Applied Subconjunctivally in a Retinal Degeneration Animal Model
by: Sofia Mickaela Martinez, et al.
Published: (2025-01-01) -
Alterations in the social-conditioned place preference and density of dopaminergic neurons in the ventral tegmental area in Clsnt2-KO mice
by: I. N. Rozhkova, et al.
Published: (2023-04-01) -
LIM-kinase 1 effects on memory abilities and male courtship song in Drosophila depend on the neuronal type
by: A. V. Zhuravlev, et al.
Published: (2023-06-01)